FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/054717 [Registered on: 04/07/2023] Trial Registered Prospectively
Last Modified On: 30/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Enema]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study to evaluate the efficacy of kukkutanda basti in hypoalbuminemia in childhood minimal changes nephrotic syndrome. 
Scientific Title of Study   An open labelled controlled clinical study to evaluate the efficacy of kukkutanda basti in hypoalbuminemia in childhood minimal changes nephrotic syndrome. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Puza Meinam 
Designation  PG Scholar  
Affiliation  Parul Institute of Ayurved  
Address  Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat-391760

Vadodara
GUJARAT
391760
India 
Phone  9035681132  
Fax    
Email  poojameinam@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dipeeka Surwase 
Designation  Associate Professor and Head of Department, Kaumarbhritya  
Affiliation  Parul Institute of Ayurved  
Address  Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat-391760

Vadodara
GUJARAT
391760
India 
Phone  9860750957  
Fax    
Email  drdipeeka77@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dipeeka Surwase 
Designation  Associate Professor and Head of Department, Kaumarbhritya  
Affiliation  Parul Institute of Ayurved  
Address  Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat-391760

Vadodara
GUJARAT
391760
India 
Phone  9860750957  
Fax    
Email  drdipeeka77@gmail.com  
 
Source of Monetary or Material Support  
Kaumarbhritya-OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat, Pin no- 391760 
 
Primary Sponsor  
Name  Parul Ayurved Hospital 
Address  Kaumarbhritya-OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat, Pin no- 391760 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Puza Meinam  Parul Ayurved Hospital  Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, 391760
Vadodara
GUJARAT 
9035681132

poojameinam@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE FOR HUMAN RESEARCH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N040||Nephrotic syndrome with minor glomerular abnormality. Ayurveda Condition: MUTRAVAHASROTOVIKARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Medical treatmentMedical treatment without basti
2Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: Charaka samhita sidhi sthana 3rd chapter, Procedure details: Prepared basti dravya will be injected through rectal route with the help of red rubber cathetor & 25-50 ml syringe. Patient will be advised for left lateral position for next 30 mins.Gently tapping of hips will be done in every patients.)
(1) Medicine Name: Egg albumin, Reference: Other than classical, Route: Rectal, Dosage Form: Not Applicable, Dose: 30(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  Age group- 3 to 10 years
Diagnosed cases of primary type of nephrotic syndrome (idiopathic) of either the
gender.
The other alternate modern treatment to be continued as per recommended dose
according to allopathy treatment protocol as per the guideline
Children with parents who agree to participate and sign informed consent 
 
ExclusionCriteria 
Details  Patients of nephrotic syndrome due to other disorders i.e SLE, drug toxicity, any
genetic disorders.
Patients of nephrotic syndrome associated with illness like cardiovascular disease, tuberculosis, immuno deficiency syndrome, etc.
Advanced or critical phase of nephrotic syndrome which requires immediate intervention like dialysis depending on history and general condition at the point of examination as found by the investigator will be excluded from the study. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To manage hypoalbuminemia through rectal route without overloading proteins  14 DAYS  
 
Secondary Outcome  
Outcome  TimePoints 
Relief in post hypoalbuminemia symptoms i.e
1.Secondary oedema
2.Anorexia 
21 days 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   19/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Introduction
Nephrotic syndrome is primarily a pediatric disorder and is 1.5 times more common in children than adults. 
The incidence is 2-3/100,000 children per year and majority of affected children will have steroid-sensitive minimal change disease. 
The characteristic features are heavy proteinurea >3-4+ /24 hr, hypoalbuminemia <2.5g/dl, edema and hyperlipidemia are often associated.
  Etiology: - approximately 90% of children with nephrotic syndrome have idiopathic causes. 
 Divided into 2 groups in children 1) MCNS (High proteinuria) and  2) Nephrotic syndrome with significance lesions (low proteinuria)
 
 MCNS protein urea pathophysiology: -  Undefined mechanisms alter the permeability of the glomerular filter, resulting in massive proteinuria.  Primary abnormality of the epithelial foot process (podocytes) 
A loss of negatively charge glycoproteins within the glomerular capillary wall. 

 MCNS Oedema Pathophysiology Resultant fall in plasma oncotic pressure leads to interstitial edema and hypovolemia, stimulates the renin-angiotensin aldosterone axis and antidiuretics hormone secretion enhances Na and H2O retention. 

 Investigation shows 3-4+ g/dl proteinuria ,Serum albumin low below 2.5g/dl, serum cholesterol and triglycerides level are elevated 
 Blood urea and creatinine within normal level except when hypovolemia and fall in renal perfusion. 

AIMS: - To study the efficacy of the kukkutanda basti in hypoalbuminemia of childhood minimal changes nephrotic syndrome. 
OBJECTIVE: -Prevention of complications due to  hypoalbuminemia. To study the role of Kukkutanda Basti in arresting or prevent the complication during the progression of childhood NS.

: Prevention of complications due to  hypoalbuminemia. To study the role of Kukkutanda Basti in arresting or prevent the complication during the progression of childhood NS.

 
Close